Haleon plc (HLN.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 02:44PM BST. Market open.
| Previous close | 330.90 |
| Open | 333.30 |
| Bid | 333.40 x N/A |
| Ask | 333.60 x N/A |
| Day's range | 331.30 - 334.20 |
| 52-week range | 306.80 - 355.00 |
| Volume | |
| Avg. volume | 26,060,160 |
| Market cap | 30.484B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 30.35 |
| EPS (TTM) | 0.11 |
| Earnings date | 29 Feb 2024 |
| Forward dividend & yield | 0.06 (1.81%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | 363.53 |
Simply Wall St.Haleon plc (LON:HLN) Shares Could Be 24% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...
ZacksPharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
ZacksGSK Outperforms Industry on Strength in Key Drugs & Vaccines
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
© 2024 Yahoo. All rights reserved.